Fundraising FoxVital Venture Capital
Venture capitalWashington · Series A–Growth · 5 people tracked
Find your way into Vital Venture Capital
Sign up to see every warm intro you have to Vital Venture Capital
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Vital Venture Capital team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Vital Venture Capital pursues a patient, value-oriented investment strategy, prioritizing companies led by founders who are honest, forthright, and operationally disciplined. The firm favors visionary leaders motivated by long-term exit value rather than high salaries, and it seeks to foster positive, innovative, and results-driven environments within its portfolio companies.
Source: firm website, verified Aug 3, 2026.
Team · 5 people
from the firm's website & public directoriesWhat they invest in
from 12 of 19 portfolio companiesBiotech ×6Healthtech ×6AI & Machine Learning ×5Deep Tech ×5Cybersecurity ×4AgTech ×2Hardware ×2Medical Devices ×2
HQs:United States×10
Investments · 19 tracked
founders shown can be your intro pathBy year:2019 · 12018 · 12016 · 12011 · 14 dated
10x Genomics offers single cell analysis technology, including its Flex assay and Flex Apex product, which use probe-based chemistry and plate-based multiplexing to profile fresh, frozen, and FFPE samples for researchers.
BiotechDeep TechHardwareHealthtechPleasanton, US
Serge Saxonov(Founder)inBen Hindson(Founder)inBrad Crutchfield(Chief Commercial Officer)Jean Philibert(Chief People Officer)Eric S Whitaker(General Counsel)inJustin McAnear(Chief Financial Officer)
Co-investorsFoothill VenturesForesite CapitalKhosla VenturesOMX VenturesPaladin Capital GroupSoftBank Vision Fund+4 more
Ginkgo Bioworks builds autonomous labs that accelerate bioengineering for applications in pharmaceutical, agricultural, and industrial biotechnology.
AgTechAI & Machine LearningBiotechDeep TechHealthtechRoboticsBoston, US
Jason Kelly(Founder)inReshma Shetty(Founder)inBarry Canton(Founder)inAustin Che(Founder)inTom Knight(Founder)inBartholomew Canton(Executive Officer)
Co-investors11.2 CapitalAllen Institute for AI (AI2) IncubatorAzure Capital PartnersB3 HoldingBlue Owl CapitalCannage Capital+62 more
Twist Bioscience develops a silicon-based synthetic DNA manufacturing platform that produces high-quality DNA, genes, and NGS reagents for customers in medicine, agriculture, and industrial chemicals.
BiotechDeep TechSemiconductorsSouth San Francisco, US
William Charles Banyai(Executive Officer, Director, Promoter)Bill James Peck(Executive Officer, Promoter)Emily Leproust(Founder)inEmily Leproust, PhD(CEO and Co-Founder of Twist)Patrick Finn(President and Chief Operating Officer)inAdam Laponis(Chief Financial Officer)in
Co-investors+ND Capital3E Bioventures CapitalARCH Venture PartnersAsset Management CompanyATEL VenturesBay City Capital+10 more
Bio-Rad Laboratories is a medical device and laboratory equipment manufacturer that integrates cybersecurity measures into product design and offers security oversight services including anti-malware solutions and monitoring tools for connected medical instruments.
BiotechCybersecurityHealthtechMedical DevicesHercules, US
Co-investorsID Ventures
Booker is an all-in-one management software platform for spas, salons, barbershops, and massage studios.
Missoula, US
Daniel Lizio-Katzen(Executive Officer)Rosemary Biagioni(Executive Officer)inJosh McCarter(Executive Officer, Director)in
BoardPeter Ellis(Director)James Pastoriza(Director)Don Rainey(Director)in
Co-investorsEscalate Capital PartnersRevolutionBain Capital VenturesGrotech VenturesJump Capital
Circadence develops gamified, cloud-based cybersecurity training and awareness platforms for individuals, teams, and government agencies.
AI & Machine LearningCybersecurityDefense TechEdTech
Michael J. Moniz(Co-founder, President, and CEO)inChristopher T. Blisard(Co-founder and Chief Operating Officer)in
Co-investorsRunway Growth CapitalSaints Capital
Isolation Bio (Galt Inc.) develops the Prospector Discovery Platform, a high-throughput, automated microbial cultivation array technology that isolates, cultivates, and screens thousands of microbes in parallel.
AgTechBiotechDeep Tech
Co-investorsVertical Venture Partners
HealthtechChandler, US
David Smith(Executive Officer)inBill Colston(Executive Officer, Director)in
BoardCraig Asher(Director)Caren Masen(Director)Carolyn Compton(Director)Paul Conley(Director)
Co-investorsThird Point Ventures
LookingGlass, now part of ZeroFox, provides attack surface monitoring enriched with threat intelligence to help organizations manage cyber risk and vulnerabilities.
AI & Machine LearningCybersecurityData & InfrastructureSaaS
Co-investorsAlsop Louie PartnersTriangle Peak PartnersNeuberger Berman
Rubryc discovers antibody-based medicines for obesity and cardiometabolic disease, using an AI-assisted platform to design antibodies for hard-to-drug targets.
AI & Machine LearningBiotechDeep TechSan Ramon, US
Paul Conley(Director)inBill Colston(Executive Officer, Director, Promoter)Jason Hong(Director)Isaac J. Bright(Executive Officer, Director)
Co-investorsThird Point VenturesPaladin Capital Group
Mclean, US
Christopher Key(Founder)inBenito A. Cianciaruso, Jr.(Executive Officer, Promoter)Chris Key(Founder)
BoardCharles Beeler(Director)Matt Bigge(Director)inJay Leek(Director)
Co-investorsBessemer Venture PartnersCheyenne VenturesCisco InvestmentsClearSkyCrosslink CapitalSyn Ventures Seed Management Llc+4 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AxioMx, Inc.HalfpennyTomabio
Exits · 5
3 IPOs · 2 acquisitions · showing 410x GenomicsNASDAQ: TXGGinkgo BioworksNYSE: DNATwist BioscienceNASDAQ: TWSTBioclinicaacq. by Clario
Portfolio news
latest coverage across their companies
Circadence · fintech.global · Mar 6, 2026
Frequently asked questions
- How many investments has Vital Venture Capital made?
- Vital Venture Capital has 19 tracked investments, 5 of which have exited.
- What stage does Vital Venture Capital invest at?
- Vital Venture Capital invests at the Series A, Series B, Growth stages.
- What is Vital Venture Capital's typical check size?
- Vital Venture Capital typically writes checks of $1M – $3M.
- What sectors does Vital Venture Capital focus on?
- Vital Venture Capital focuses on Digital Health, Enterprise Software, Healthtech, Medical Devices, SaaS.
- Where is Vital Venture Capital located?
- Vital Venture Capital is headquartered in Washington, US.
- Does Vital Venture Capital lead rounds?
- Yes, Vital Venture Capital leads investment rounds.
- Who does Vital Venture Capital co-invest with?
- Vital Venture Capital most often shares deals with OMX Ventures, iGlobe Partners, Khosla Ventures, among 65 tracked co-investors.
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.